Eli Lilly & Co. (LLY) Raises FY23 Revenue Guidance to $33.4B-$33.9B vs Prior Guidance of $31.2B-$31.7B
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,306.69 +2.83%
Revenue Growth %: +27.4%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
ORPB, PBCO, SICP, More
Revenue Growth %: +27.4%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
ORPB, PBCO, SICP, More
Join SI Premium – FREE
Eli Lilly & Co. (LLY) Raises FY23 Revenue Guidance to $33.4B-$33.9B vs Prior Guidance of $31.2B-$31.7B
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lilly breaks ground on $5B Virginia drug manufacturing facility
- XTI Aerospace reports preliminary Q3 revenue of $35.3 million
- Eli Lilly shares climb on positive pediatric ulcerative colitis trial
Create E-mail Alert Related Categories
Corporate News, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
